Clinical Trials in Houston

Showing 7581-7600 of 13,620 trials

A Study of LY3361237 in Participants With Systemic Lupus Erythematosus

NCT03933943

The main purpose of this study is to learn more about the safety of LY3361237 and any side effects that might be associated with it when given to participants with systemic lupus erythematosis (SLE). LY3361237 will be administered by injections just under the skin. The study will last up to 26 weeks and may include up to 17 visits to the study center.

Lupus Erythematosus, Systemic

Eli Lilly and Company28 participantsStarted May 2019

Anniston, Alabama, United States • Clearwater, Florida, United States • Tampa, Florida, United States +6 more locations

COMPLETEDNA< 1 mile

MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue

NCT02680535

To determine the efficacy of using MRI/US fusion imaging technology to direct focal ablation of prostate tissue using nanoparticle-directed laser irradiation.

Neoplasms of the Prostate

Nanospectra Biosciences, Inc.45 participantsStarted Feb 2016

Baltimore, Maryland, United States • Ann Arbor, Michigan, United States • New York, New York, United States +2 more locations

A Study of LY3361237 in Participants With Systemic Lupus Erythematosus

MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue

Find Trials by Condition in Houston

Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen

Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma

Feasibility of Healthy Dads Healthy Kids Latino

Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant

Carisbamate as a Potential Treatment for Alcohol Dependence

Dose-ranging Study for Postoperative Analgesia in Subjects Undergoing Primary Unilateral Inguinal Hernia Repair

A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer

Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate

Validating a New Method to Assess Estimated Blood Loss in the Obstetric Population

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.

Automated Graduated CPAP (AGPAP) for Improved Adherence in Newly Diagnosed Obstructive Sleep Apnea (OSA) Patients

An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)

A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Hemodialysis Access Surveillance Evaluation Study